Jaime Bartushak
2022
In 2022, Jaime Bartushak earned a total compensation of $809K as Chief Financial Officer and Chief Business Officer at Citius Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,000 |
|---|---|
| Option Awards | $281,034 |
| Salary | $356,250 |
| Other | $39,717 |
| Total | $809,001 |
Bartushak received $356.3K in salary, accounting for 44% of the total pay in 2022.
Bartushak also received $132K in non-equity incentive plan, $281K in option awards and $39.7K in other compensation.
Rankings
In 2022, Jaime Bartushak's compensation ranked 3,477th out of 5,756 executives tracked by ExecPay. In other words, Bartushak earned more than 39.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,477 out of 5,756 | 40th |
Division Manufacturing | 1,970 out of 3,133 | 37th |
Major group Chemicals And Allied Products | 941 out of 1,419 | 34th |
Industry group Drugs | 880 out of 1,320 | 33rd |
Industry Pharmaceutical Preparations | 643 out of 966 | 33rd |
Source: SEC filing on December 22, 2022.
Bartushak's colleagues
We found three more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2022.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018